Anticipated barriers and facilitators for implementing smart inhalers in asthma medication adherence management.

IF 3.1 3区 医学 Q1 PRIMARY HEALTH CARE
Susanne J van de Hei, Nilouq Stoker, Bertine M J Flokstra-de Blok, Charlotte C Poot, Eline Meijer, Maarten J Postma, Niels H Chavannes, Janwillem W H Kocks, Job F M van Boven
{"title":"Anticipated barriers and facilitators for implementing smart inhalers in asthma medication adherence management.","authors":"Susanne J van de Hei,&nbsp;Nilouq Stoker,&nbsp;Bertine M J Flokstra-de Blok,&nbsp;Charlotte C Poot,&nbsp;Eline Meijer,&nbsp;Maarten J Postma,&nbsp;Niels H Chavannes,&nbsp;Janwillem W H Kocks,&nbsp;Job F M van Boven","doi":"10.1038/s41533-023-00343-w","DOIUrl":null,"url":null,"abstract":"<p><p>Smart inhalers are electronic monitoring devices which are promising in increasing medication adherence and maintaining asthma control. A multi-stakeholder capacity and needs assessment is recommended prior to implementation in healthcare systems. This study aimed to explore perceptions of stakeholders and to identify anticipated facilitators and barriers associated with the implementation of smart digital inhalers in the Dutch healthcare system. Data were collected through focus group discussions with female patients with asthma (n = 9) and healthcare professionals (n = 7) and through individual semi-structured interviews with policy makers (n = 4) and smart inhaler developers (n = 4). Data were analysed using the Framework method. Five themes were identified: (i) perceived benefits, (ii) usability, (iii) feasibility, (iv) payment and reimbursement, and (v) data safety and ownership. In total, 14 barriers and 32 facilitators were found among all stakeholders. The results of this study could contribute to the design of a tailored implementation strategy for smart inhalers in daily practice.</p>","PeriodicalId":19470,"journal":{"name":"NPJ Primary Care Respiratory Medicine","volume":"33 1","pages":"22"},"PeriodicalIF":3.1000,"publicationDate":"2023-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198788/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Primary Care Respiratory Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41533-023-00343-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 2

Abstract

Smart inhalers are electronic monitoring devices which are promising in increasing medication adherence and maintaining asthma control. A multi-stakeholder capacity and needs assessment is recommended prior to implementation in healthcare systems. This study aimed to explore perceptions of stakeholders and to identify anticipated facilitators and barriers associated with the implementation of smart digital inhalers in the Dutch healthcare system. Data were collected through focus group discussions with female patients with asthma (n = 9) and healthcare professionals (n = 7) and through individual semi-structured interviews with policy makers (n = 4) and smart inhaler developers (n = 4). Data were analysed using the Framework method. Five themes were identified: (i) perceived benefits, (ii) usability, (iii) feasibility, (iv) payment and reimbursement, and (v) data safety and ownership. In total, 14 barriers and 32 facilitators were found among all stakeholders. The results of this study could contribute to the design of a tailored implementation strategy for smart inhalers in daily practice.

在哮喘药物依从性管理中实施智能吸入器的预期障碍和促进因素。
智能吸入器是一种电子监测设备,有望增加药物依从性和维持哮喘控制。建议在卫生保健系统实施之前进行多利益攸关方能力和需求评估。本研究旨在探讨利益相关者的看法,并确定与荷兰医疗保健系统中智能数字吸入器实施相关的预期促进因素和障碍。通过与女性哮喘患者(n = 9)和医疗保健专业人员(n = 7)的焦点小组讨论,以及与政策制定者(n = 4)和智能吸入器开发人员(n = 4)的个人半结构化访谈,收集数据。采用Framework方法对数据进行分析。确定了五个主题:(i)感知收益,(ii)可用性,(iii)可行性,(iv)支付和报销,以及(v)数据安全性和所有权。在所有利益相关者中,总共发现了14个障碍和32个促进因素。这项研究的结果可能有助于在日常实践中为智能吸入器设计量身定制的实施策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NPJ Primary Care Respiratory Medicine
NPJ Primary Care Respiratory Medicine PRIMARY HEALTH CARE-RESPIRATORY SYSTEM
CiteScore
5.50
自引率
6.50%
发文量
49
审稿时长
10 weeks
期刊介绍: npj Primary Care Respiratory Medicine is an open access, online-only, multidisciplinary journal dedicated to publishing high-quality research in all areas of the primary care management of respiratory and respiratory-related allergic diseases. Papers published by the journal represent important advances of significance to specialists within the fields of primary care and respiratory medicine. We are particularly interested in receiving papers in relation to the following aspects of respiratory medicine, respiratory-related allergic diseases and tobacco control: epidemiology prevention clinical care service delivery and organisation of healthcare (including implementation science) global health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信